All-trans-retinoic acid inhibits the proliferation of cell lines derived from human cervical neoplasia

Gynecologic Oncology

Volumn 61, Issue 1, 1996, Pages 31-39

  Behbakht, Kian ^a,b   Degeest, Koen ^a   Turyk, Mary E ^a   Wilbanks, George D ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CARCINOMA CELL; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA SYNTHESIS; DOSE RESPONSE; FEMALE; GROWTH DISORDER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0029870643     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0092     Document Type: Article

References (30)

1. McBurney, M. W., Costa, S., and Pratt, M. A. C. Retinoids and cancer: A basis for differentiation therapy, Cancer Invest. 11, 590-598 (1993).
2. Meng-er, H., Yu-chen, Y., Shu-rong, C., Jin-ren, C., Jia-Xiang, L., Lin, Z., Long-jun, G., and Zhen-yi, W. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia, Blood 2, 567-572 (1988).
3. Smith, M. A., Rakinson, D. R., Cheson, B. D., and Friedman, M. A. Retinoids in cancer therapy, J. Clin. Oncol. 10, 839-864 (1992).
4. Graham, V., Surwit, E. A., Weiner, F. L., and Meyskens, F. L. Phase II trial of β-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap, West. J. Med. 145, 192 (1986).
5. Meyskens, F. L., Graham, V., Chvapil, M., Dorr, R. T., Alberts, D. S., and Surwit, E. A. A Phase I trial of β-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia, J. Natl. Cancer Inst. 71, 921 (1983).
6. Meyskens, F. L., and Surwit, E. A. Clinical experience with topicasl tretinoin in the treatment of cervical dysplasia, J. Am. Acad. Dermatol. 15, 826 (1986).
7. Peng, Y. M., Alberts, D. S., Graham, V., Surwit, E. A., Weiner, S., and Meyskens, F. L. Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery system in patients with cervical dysplasia, Invest. New Drugs 4, 245 (1986).
8. Surwit, E. A., Graham, V., Droegemueller, W., Alberts, D., Chvapil, M., Dorr, R. T., Davis, J. R., and Meyskens, F. L. Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions, Am. J. Obstet. Gynecol. 143, 821 (1982).
9. Weiner, S. A., Surwit, E. A., Graham, V. E., and Meyskens, F. L. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia - Clinical efficacy, Invest. New Drugs 4, 241 (1986).
10. Sporn, M. B., and Roberts, A. B. Regulation of cell differentiation and proliferation by retinoids and transforming growth factor β, in Cell to cell interaction (M. M. Burger and B. Sordat, Eds.), Karger, Basel, pp. 2-15 (1990).
11. Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M. T., Fenaux, P., Castaigne, S., and Degos, L. All-trans-retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship, Blood 76, 1710-1717 (1990).
12. Breitman, T., Selonic, S., and Collins, S. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid, Proc. Natl. Acad. Sci. USA 77, 2936-2940 (1980).
13. Breitman, T., Collins, S., and Keene, B. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid, Blood 57, 1000-1004 (1981).
14. Breitman, T., Keene, B., and Hemmi, H. Retinoic acid-induced differentiation of fresh human leukemia cells and the human myelomonocytic leukemia cell lines, HL-60, U-937, and THP-1, Cancer Surv. 2, 261-291 (1983).
15. Koeffler, H., and Amatruda, T. The effect of retinoids on hemopoiesis - Clinical and laboratory studies, in Retinoids, differentiation and disease (J. Nugent and S. Clark, Eds.), Ciba Foundation, London, pp. 252-273 (1985).
16. Kopan, R., Transka, G., and Fuchs, E. Retinoids as important regulators of terminal differentiation: Examining keratin expression in individual epidermal cells at various stages of keratinization, J. Cell Biol. 105, 427-440 (1987).
17. Sporn, M., Clamon, G., and Dunlop, N. Activity of vitamin A analogues in cell cultures of mouse epidermis and organ cultures of hamster trachea, Nature 253, 47-50 (1975).
18. Jetten, A., Kim, J., and Sacks, P. Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by B-all-trans-retinoic acid, Int. J. Cancer 45, 195-202 (1990).
19. Sacks, P., Oke, V., and Amos, B. Modulation of growth, differentiation, and glycoprotein synthesis by B-all-trans-retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck, Int. J. Cancer 44, 926-933 (1989).
20. Batova, A., Danielpour, D., and Pirisi, L. Retinoic acid induces secretion of latent transforming growth factor β1 and β2 in normal and human papillomavirus type 16-immortalized human keratinocytes, Cell Growth Differ. 3, 763 (1992).
21. DeGeest, K., Bergman, C. A., Turyk, M. E., Frank, B. S., and Wilbanks, G. D. Differential response of cervical intraepithelial and cervical carcinoma cell lines to transforming growth factor β1, Gynecol. Oncol. 55, 376-385 (1994).
22. Lippman, S. M., Kavanagh, J. J., Paredes-Espinoza, M., Gelgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Massimini, G., Holdener, E. E., and Krakoff, I. R. 13-cis-Retinoic acid plus interferon-α2a in locally advanced squamous cell carcinoma of the cervix, J. Natl. Cancer Inst. 85, 499-500 (1993).
23. Turyk, M. E., Golub, T. R., Wood, N. B., Hawkins, J. L., and Wilbanks, G. D. Growth and characterization of epithelial cells from normal human uterine ectocervix and endocervix, In Vitro Cell Dev. Biol. 25, 544-555 (1989).
24. De Geest, K., Turyk, M. E., Hosken, M. I., Hudson, J. B., Laimins, L. A., and Wilbanks, G. D. Growth and differentiation of human papillomavirus type 31b-positive human cervical cell lines, Gynecol. Oncol. 49, 303-310 (1993).
25. Danielpour, D. Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor β1, J. Immunol. Methods 158, 17-25 (1993).
26. Pirisi, L., Batova, A., Jenkins, G. R., Hodam, J. R., and Creek, K. E. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids, Cancer Res. 52, 187-193 (1992).
27. Frangioni, J. V., Moghal, N., Stuart-Tilley, A., Neel, B. G., and Apler, S. L. The DNA binding domain of retinoic acid receptor beta is required for ligand-dependent suppression of proliferation: Application of general purpose mammalian coexpression vectors, J. Cell Sci. 107, 827-838 (1994).
28. Sheikh, M. S., Shao, Z. M., Li, X. S., Dawson, M., Jetten, A. M., Wu, S., Conley, B. A., Garcia, M., Rochefort, H., and Fontana, J. A. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids, J. Biol. Chem, 262, 21440-21447 (1994).
29. Andreatta-Van Leyen, S., Hembree, J. R., and Eckert, R. L. Regulation of insulin-like growth factor 1 binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells, J. Cell. Physiol. 160, 265-274 (1994).
30. Lacillotti, F., Darwiche, N., Celli, G., and De Luca, L. M. Retinoid status and the control of keratin expression and adhesion during the histogenesis of squamous metaplasia of tracheal epithelium, Cancer Res. 52, 6144-6152 (1992).